McKesson Corporation (0JZU.L)
USD 705.49
(-0.86%)
USD 705.49
(-0.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 3 Billion USD | -15.67% |
| 2022 | 3.56 Billion USD | 219.57% |
| 2021 | 1.11 Billion USD | 124.54% |
| 2020 | -4.53 Billion USD | -604.33% |
| 2019 | 900 Million USD | 2547.06% |
| 2018 | 34 Million USD | -49.25% |
| 2017 | 67 Million USD | -98.71% |
| 2016 | 5.18 Billion USD | 129.54% |
| 2015 | 2.25 Billion USD | 27.21% |
| 2014 | 1.77 Billion USD | 25.09% |
| 2013 | 1.41 Billion USD | 4.11% |
| 2012 | 1.36 Billion USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 915 Million USD | 15.68% |
| 2023 Q1 | 958 Million USD | 21.73% |
| 2023 Q2 | 664 Million USD | -30.69% |
| 2023 FY | 3 Billion USD | -15.67% |
| 2023 Q3 | 589 Million USD | -11.3% |
| 2023 Q4 | 791 Million USD | 34.3% |
| 2022 Q2 | 926 Million USD | 20.57% |
| 2022 Q1 | 768 Million USD | 108.7% |
| 2022 Q4 | 787 Million USD | -27.06% |
| 2022 FY | 3.56 Billion USD | 219.57% |
| 2022 Q3 | 1.07 Billion USD | 16.52% |
| 2021 FY | 1.11 Billion USD | 124.54% |
| 2021 Q1 | 486 Million USD | -27.03% |
| 2021 Q2 | 267 Million USD | -45.06% |
| 2021 Q4 | 368 Million USD | 5357.14% |
| 2021 Q3 | -7 Million USD | -102.62% |
| 2020 Q4 | 666 Million USD | 110.7% |
| 2020 FY | -4.53 Billion USD | -604.33% |
| 2020 Q1 | 445 Million USD | -56.16% |
| 2020 Q2 | 577 Million USD | 29.66% |
| 2020 Q3 | -6.22 Billion USD | -1179.03% |
| 2019 Q3 | 191 Million USD | 126.2% |
| 2019 Q4 | 1.01 Billion USD | 431.41% |
| 2019 Q1 | 429 Million USD | 153.89% |
| 2019 Q2 | -729 Million USD | -269.93% |
| 2019 FY | 900 Million USD | 2547.06% |
| 2018 FY | 34 Million USD | -49.25% |
| 2018 Q4 | -796 Million USD | -269.36% |
| 2018 Q3 | 470 Million USD | -5.62% |
| 2018 Q2 | 498 Million USD | 458.27% |
| 2018 Q1 | -139 Million USD | 87.89% |
| 2017 Q1 | 307 Million USD | -91.46% |
| 2017 Q2 | 1 Million USD | -99.67% |
| 2017 Q3 | 902 Million USD | 90100.0% |
| 2017 Q4 | -1.14 Billion USD | -227.27% |
| 2017 FY | 67 Million USD | -98.71% |
| 2016 FY | 5.18 Billion USD | 129.54% |
| 2016 Q4 | 3.59 Billion USD | 465.25% |
| 2016 Q3 | 636 Million USD | 106.49% |
| 2016 Q2 | 308 Million USD | -52.98% |
| 2016 Q1 | 655 Million USD | 44.91% |
| 2015 FY | 2.25 Billion USD | 27.21% |
| 2015 Q4 | 452 Million USD | -28.14% |
| 2015 Q3 | 629 Million USD | 0.96% |
| 2015 Q1 | 586 Million USD | 46.87% |
| 2015 Q2 | 623 Million USD | 6.31% |
| 2014 Q4 | 399 Million USD | -17.22% |
| 2014 FY | 1.77 Billion USD | 25.09% |
| 2014 Q1 | 411 Million USD | 1.73% |
| 2014 Q2 | 483 Million USD | 17.52% |
| 2014 Q3 | 482 Million USD | -0.21% |
| 2013 FY | 1.41 Billion USD | 4.11% |
| 2013 Q1 | 428 Million USD | 62.74% |
| 2013 Q3 | 164 Million USD | -61.23% |
| 2013 Q4 | 404 Million USD | 146.34% |
| 2013 Q2 | 423 Million USD | -1.17% |
| 2012 Q3 | 306 Million USD | 0.0% |
| 2012 Q4 | 263 Million USD | -14.05% |
| 2012 FY | 1.36 Billion USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 2293.082% |
| Accuray Incorporated | -15.54 Million USD | 19411.676% |
| Align Technology, Inc. | 445.05 Million USD | -574.526% |
| Elevance Health Inc. | 5.98 Billion USD | 49.858% |
| AxoGen, Inc. | -21.71 Million USD | 13923.909% |
| Boston Scientific Corporation | 1.59 Billion USD | -88.449% |
| CVS Health Corporation | 8.34 Billion USD | 64.022% |
| Cardinal Health, Inc. | 852 Million USD | -252.347% |
| Centene Corporation | 2.7 Billion USD | -11.103% |
| DaVita Inc. | 691.53 Million USD | -334.107% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 42.732% |
| Hologic, Inc. | 789.5 Million USD | -280.241% |
| Humana Inc. | 2.48 Billion USD | -20.611% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | -255.249% |
| Laboratory Corporation of America Holdings | 418 Million USD | -618.182% |
| Masimo Corporation | 81.5 Million USD | -3583.436% |
| Patterson Companies, Inc. | 185.93 Million USD | -1514.577% |
| Quest Diagnostics Incorporated | 854 Million USD | -251.522% |
| ResMed Inc. | 1.02 Billion USD | -194.04% |
| Henry Schein, Inc. | 416 Million USD | -621.635% |
| Teladoc Health, Inc. | -220.36 Million USD | 1462.267% |
| Universal Health Services, Inc. | 717.79 Million USD | -318.225% |
| Veeva Systems Inc. | 525.7 Million USD | -471.043% |
| Baxter International Inc. | 2.65 Billion USD | -13.027% |
| Becton, Dickinson and Company | 1.48 Billion USD | -102.291% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | -66.963% |
| Danaher Corporation | 4.2 Billion USD | 28.524% |
| Stryker Corporation | 3.16 Billion USD | 5.15% |
| Medtronic plc | 3.67 Billion USD | 18.335% |